Last reviewed · How we verify
NCT04001686: IISAPM201701
Ambispective Observational Study to Evaluate the Incidence and Management of Aplastic Anemia in Spain
trial testing incidence aplastic anemia in Aplastic Anemia in 109 participants. Status unknown.
1 September 2021
Quick facts
| Lead sponsor | Biogipuzkoa Health Research Institute |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 109 |
| Start date | 31 January 2018 |
| Primary completion | 1 September 2021 |
| Estimated completion | 30 September 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- incidence aplastic anemia
Conditions studied
- Aplastic Anemia — all drugs for Aplastic Anemia →
Sponsor
Biogipuzkoa Health Research Institute
Who can join
Eligibility, any sex, with Aplastic Anemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a national, multicenter, ambispective, observational post-authorization study (EPA-SP for its acronym in Spanish) to describe the incidence, clinical management and outcome of aplastic anemia in hospitals throughout Spain.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04001686
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aplastic Anemia
Currently open trials in the same condition.
- NCT07101770 — A Prediction Model in Pregnant Women With Aplastic Anemia · recruiting
- NCT06752694 — Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult P · Phase 2 · recruiting
- NCT06936930 — Reproductive and Mental Health of Patients With Aplastic Anemia · recruiting
- NCT06689800 — Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy · NA · recruiting
- NCT06613880 — Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia · Phase 2 · recruiting
Other Biogipuzkoa Health Research Institute trials
Trials by the same sponsor.
- NCT07270393 — Study of the Influence of the Mediterranean Diet on the Quality of Life of Patients With Endometriosis. · NA · not yet recruiting
- NCT07414212 — Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosi · Phase 1, PHASE2 · recruiting
- NCT06660446 — Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study. · NA · recruiting
- NCT05489185 — Clinical Trial to Assess the Efficacy of Tranexamic Acid in Reducing Blood Loss in Hip Fracture Patients. · Phase 4 · unknown
- NCT05622760 — Impact of the Different Information Channels in Reducing Anxiety in Participants of Cervical Cancer Screening · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04001686 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Biogipuzkoa Health Research Institute
- Last refreshed: 10 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04001686.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing